Bristol-Myers Squibb Co’s recent filing unveils that its Chief Executive Officer BOERNER CHRISTOPHER S. acquired Company’s shares for reported $0.11 million on Feb 20 ’25. In the deal valued at $55.05 per share,2,000 shares were bought. As a result of this transaction, BOERNER CHRISTOPHER S. now holds 104,626 shares worth roughly $5.31 million.
Then, Hirawat Samit bought 1,823 shares, generating $100,000 in total proceeds. Upon buying the shares at $54.84, the EVP,Chief Med.Offr.,Drug Dev. now owns 63,932 shares.
Before that, Holzer Phil M sold 700 shares. Bristol-Myers Squibb Co shares valued at $38,930 were divested by the SVP and Controller at a price of $55.62 per share. As a result of the transaction, Holzer Phil M now holds 11,760 shares, worth roughly $0.6 million.
Jefferies upgraded its Bristol-Myers Squibb Co [BMY] rating to a Buy from a a Hold in a research note published recently. Wolfe Research began covering BMY with “Peer perform” recommendation on November 15, 2024. Daiwa Securities revised its rating on November 13, 2024. It rated BMY as “an Outperform” which previously was an “a Neutral”.
Price Performance Review of BMY
On Friday, Bristol-Myers Squibb Co [NYSE:BMY] saw its stock jump 0.50% to $50.71. Over the last five days, the stock has lost -8.30%. Bristol-Myers Squibb Co shares have fallen nearly -10.34% since the year began. Nevertheless, the stocks have risen 0.84% over the past one year. While a 52-week high of $63.33 was reached on 03/11/25, a 52-week low of $39.35 was recorded on 04/10/25. SMA at 50 days reached $58.06, while 200 days put it at $53.48.
Levels Of Support And Resistance For BMY Stock
The 24-hour chart illustrates a support level at 49.66, which if violated will result in even more drops to 48.62. On the upside, there is a resistance level at 51.38. A further resistance level may holdings at 52.06. The Relative Strength Index (RSI) on the 14-day chart is 26.87, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -5.06, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 85.26%. Stochastics %K at 20.04% indicates the stock is a holding.
How much short interest is there in Bristol-Myers Squibb Co?
A steep rise in short interest was recorded in Bristol-Myers Squibb Co stocks on 2025-03-31, dropping by -1.17 million shares to a total of 29.4 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 30.57 million shares. There was a decline of -3.99%, which implies that there is a negative sentiment for the stock.
